Fair questions and concern why not ring him and ask.
I would have thought his appointment as a director is relevant to ARQ shareholders. We have a advantage indirectly but I dont see why it would be announced here.Of course if it was an activists' move then he could assuage your concerns by releasing a memo.
.. its a jungle out there.
- Forums
- ASX - By Stock
- CDM
- Karl Seigerling on the board of ARQ
Karl Seigerling on the board of ARQ, page-9
Featured News
Add CDM (ASX) to my watchlist
(20min delay)
|
|||||
Last
75.5¢ |
Change
0.005(0.67%) |
Mkt cap ! $224.8M |
Open | High | Low | Value | Volume |
76.0¢ | 76.0¢ | 75.5¢ | $115.4K | 152.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 81062 | 75.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
76.0¢ | 41674 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 71062 | 0.750 |
3 | 32686 | 0.745 |
3 | 29210 | 0.740 |
4 | 69787 | 0.735 |
4 | 50070 | 0.730 |
Price($) | Vol. | No. |
---|---|---|
0.760 | 41674 | 4 |
0.765 | 87000 | 7 |
0.770 | 205137 | 5 |
0.775 | 10820 | 2 |
0.780 | 4563 | 2 |
Last trade - 15.53pm 10/10/2024 (20 minute delay) ? |
Featured News
CDM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online